Evaluating the impact of non-pharmaceutical interventions for SARS-CoV-2 on a global scale
Rachel Esra, Lise Jamieson, Matthew P. Fox, Daniel Letswalo, Nkosinathi Ngcobo, Sithabile Mngadi, Janne Estill, Gesine Meyer-Rath, Olivia Keiser
doi: https://doi.org/10.1101/2020.07.30.20164939
Rachel Esra
1Division of Infectious Diseases and Mathematical Modelling, Institute of Global Health, Faculty of medicine; University of Geneva, Geneva, Switzerland,
2Health Economics and Epidemiology Research Office (HE2RO), Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa,
Lise Jamieson
2Health Economics and Epidemiology Research Office (HE2RO), Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa,
Matthew P. Fox
2Health Economics and Epidemiology Research Office (HE2RO), Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa,
3Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, United States of America
Daniel Letswalo
2Health Economics and Epidemiology Research Office (HE2RO), Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa,
Nkosinathi Ngcobo
2Health Economics and Epidemiology Research Office (HE2RO), Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa,
Sithabile Mngadi
2Health Economics and Epidemiology Research Office (HE2RO), Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa,
Janne Estill
1Division of Infectious Diseases and Mathematical Modelling, Institute of Global Health, Faculty of medicine; University of Geneva, Geneva, Switzerland,
Gesine Meyer-Rath
2Health Economics and Epidemiology Research Office (HE2RO), Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa,
3Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, United States of America
Olivia Keiser
1Division of Infectious Diseases and Mathematical Modelling, Institute of Global Health, Faculty of medicine; University of Geneva, Geneva, Switzerland,
Article usage
Posted August 05, 2020.
Evaluating the impact of non-pharmaceutical interventions for SARS-CoV-2 on a global scale
Rachel Esra, Lise Jamieson, Matthew P. Fox, Daniel Letswalo, Nkosinathi Ngcobo, Sithabile Mngadi, Janne Estill, Gesine Meyer-Rath, Olivia Keiser
medRxiv 2020.07.30.20164939; doi: https://doi.org/10.1101/2020.07.30.20164939
Evaluating the impact of non-pharmaceutical interventions for SARS-CoV-2 on a global scale
Rachel Esra, Lise Jamieson, Matthew P. Fox, Daniel Letswalo, Nkosinathi Ngcobo, Sithabile Mngadi, Janne Estill, Gesine Meyer-Rath, Olivia Keiser
medRxiv 2020.07.30.20164939; doi: https://doi.org/10.1101/2020.07.30.20164939
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)